기업
TMD LAB Appointed as an Entity in Charge of the National Project of R&D of Reliable Medical Equipment by the Incorporation of Government Agencies
by Yoonseok Suh
The Consortium of College of Medicine of Yonsei University-TMD LAB-Carima Launched the Project of Development of Temperature Sensitive Auxiliary Medical Equipment for Anastomosis of Blood Vessels
TMD LAB announced that the company was appointed as an entity responsible for the development of “Materials and Elements for the Customized Medical Equipment” by the “National Research Foundation of Korea”, supported by the “Incorporation of Government Agencies for the Research and Development Project for Reliable Medical Equipment”, on September 15. TMD LAB is a company developing implantable medical equipment by using the shape memory polymers.
The faculty of the College of Medicine at Yonsei University, led by Professor Seong Hak-jun, was appointed as the “Supervisory Research Institution” for the national project wherein TAM LAB and Carima, the exclusive company of 3D Printing, participate in the consortium. Professor Seong Hak-jun is also a registered director of TMD LAB; he was a professor at the Georgia Institute of Technology and Vanderbilt University, and is regarded as an authority in the field of polymer science.
The consortium of the College of Medicine at Yonsei University-TMD LAB-Carima will be engaging in the development of “Temperature Sensitive Auxiliary Medical Equipment for Anastomosis of Blood Vessels”. The commercial product of the implantable polymer medical device, enables the prevention of intravascular constriction during the execution of surgical operations such as organ transplantation or breast reconstruction etc., will be developed by the consortium, for which a total of 2.5-billion KRW, of entire project budget of 3-billion KRW, will be supported by the government for four years of development.
The College of Medicine at Yonsei University, responsible for the supervision of R&D activities of the consortium, will also manage the securing of biological safety, physical properties, performance evaluation, and preclinical trial of the pilot product. TMD LAB will participate in the development of bio-sensitive tensile polymer materials of the improved strength and system of the mass-synthesis of polymers, while Carima will develop 3D-Printing based manufacturing technology for the pilot product.
President Kang Mi-ran of TMD LAB explained, “… The medical equipment or similarities involved in anastomosis of blood vessels, to prevent intravascular constriction and regeneration of blood-vessels, are yet to be introduced …”, “… the original technology of shape memory polymers sensitive to body temperature of TMD LAB can be applicable to the market of diverse implantable medical equipment including stent insertion into vascular- or non-vascular vessels, artificial tissue, and needle-type patch etc.”.
Meanwhile, TMDLAB was appointed as an institution responsible for the supervision of “Strategic Start-up Projects” with the development of medical equipment exploiting shape memory polymers by the Ministry of SMEs and Startups last July.
